Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(1):11-15 | DOI: 10.5507/bp.2007.002

WWOX, A NEW POTENTIAL TUMOR SUPPRESSOR GENE

Renata Hezova, Jiri Ehrmann, Zdenek Kolar
Department of Pathology & Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 775 15, Czech Republic

Background: WWOX (WW domain-containing oxidoreductase) gene, located on chromosome 16q 23.3-24.1 in the region recognized as the common fragile site FRA16D is considered to be a tumor suppressor gene involved in various cancers: breast, ovarian, prostate, esophageal, lung, pancreatic, gastric and hepatic. The aim of this study was to describe (i) putative protein interactions of WWOX (ii) the molecular mechanisms of tumor suppressor activity (iii) present an overview of WWOX in relation to nervous system and breast, prostate and ovarian cancers.

Methods and Results: WWOX expression is up-regulated in endocrine organs indicating its importance in these tissues. In many cancers WWOX expression is down-regulated and low WWOX expression is related to poor prognosis.

Conclusion: All the evidence suggest that WWOX can be considered as a new tumor suppressor gene and target for gene therapy due to the association of high WWOX expression with improved disease free survival.

Keywords: WWOX, Tumor suppressor, Steroid dependent cancers, Nervous system

Received: September 7, 2006; Accepted: February 1, 2007; Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Hezova, R., Ehrmann, J., & Kolar, Z. (2007). WWOX, A NEW POTENTIAL TUMOR SUPPRESSOR GENE. Biomedical papers, 151(1), 11-15. doi: 10.5507/bp.2007.002
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sato T, Tanigami A., Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y. (1990) Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990; 50:71847189.
    2. Tsuda H, Callen D, Fukutomi T, Nakamura Y, Hirohashi S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancer irrespectively of diff erences in phenotype and extent of spread. Cancer Res 1994; 54:513517.
    3. Cleton-Jansen A., Moerland E., Kuipers-Dijkshoorn N, Callen D, Sutherland G, Hansen B, Devilee P, Cornelisse C. At least two diff erent regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994; 9:101107. Go to original source...
    4. Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 1995; 55:39763981.
    5. Chen T, Sahin A, Aldaz C. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refi ning a putative tumor suppressor gene region. Cancer Res 1996; 56:56055609. Go to original source...
    6. Carter BS, Ewing CM., Ward WS, Treiger BF, Aalders TW, Schalken JA., Epstein JI., Isaacs WB. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. 1990; 87:87518755. Go to original source...
    7. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer 1992; 51:862868. Go to original source... Go to PubMed...
    8. Bednarek AK, Lafl in KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a Novel WW Domain-containing Protein Mapping to Human Chromosome16q23.324.1, a Region Frequently Aff ected in Breast Cancer, Cancer Res 2000; 60:21402145.
    9. Bork P, Sudol M. The WW domain: a signalling site in dystrophin. Trends Biochem. Sci. 1994; 19:531533. Go to original source... Go to PubMed...
    10. Andre B, Springael JY. WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yesassociated protein YAP65. Biochem. Biophys. Res. Commun. 1994; 205:12011205. Go to original source... Go to PubMed...
    11. Hofmann K, and Bucher P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem. Sci. 1995; 20:347349. Go to original source... Go to PubMed...
    12. Ilsley JL, Sudol M, Winder SJ. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signalling 2002; 14:183189. Go to original source... Go to PubMed...
    13. Macias MJ, Wiesner S, Sudol M. WW and SH3 domains, two different scaff olds to recognize proline-rich ligands. FEBS Lett 2002; 513:3037. Go to original source... Go to PubMed...
    14. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. Common chromosomal fragile site FRA16D sequence: identifi cation of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 2000; 9:1651 63. Go to original source... Go to PubMed...
    15. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci 2001; 98:1141722. Go to original source... Go to PubMed...
    16. Kuroki T, Trapasso F, Shiraishi T, Alder H, Mimori K, Mori M, Croce CM. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 2002; 62:225860.
    17. Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, Huebner K, Williams NN, Kaiser LR, Croce CM. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res 2003; 63:87881.
    18. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML, Williams NN, Mori M, Kanematsu T, Croce CM. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 2004; 10:245965. Go to original source... Go to PubMed...
    19. Aqeilan R, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baff a R, Huebner K, Edmonds P, Croce CM. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 2004; 10:30538. Go to original source... Go to PubMed...
    20. OKeefe LV, Liu Y, Perkins A, Dayan S, Saint R, Richards RI. FRA16D common chromosomal fragile site oxido-reductase (FOR/WWOX) protects against the eff ects of ionizing radiation in Drosophila. Oncogene 2005; 24:65906596 Go to original source...
    21. Sogame N, Kim M, Abrams JM. Drosophila p53 preserves genomic stability by regulating cell death. Proc Natl Acad Sci 2003; 100:46964701. Go to original source... Go to PubMed...
    22. Lee JH, Lee E, Park J, Kim E, Kim J. Chung J. In vivo p53 function is indispensable for DNA damageinduced apoptotic signaling in Drosophila. FEBS Lett 2003; 550:510. Go to original source... Go to PubMed...
    23. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc. Natl. Acad. Sci. 2001; 98:1141711422. Go to original source...
    24. Driouch K, Dorion-Bonnet F, Briff od M, Champeme MH, Longy M, Lidereau R Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.. Genes Chromosomes Cancer 1997; 19:185191. Go to original source...
    25. Buerger H, Otterbach F, Simon R. Diff erent genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol. 1999; 189:521526. Go to original source... Go to PubMed...
    26. Roylance R, Gorman P, Hanby A, Tomlinson I. Allelic imbalance analysis of chromosome 16q shows that Grade I and Grade III invasive ductal breast cancers follow diff erent genetic pathways. J Pathol. 2002; 196:3236. Go to original source... Go to PubMed...
    27. Buerger H, Mommers EC, Littmann R, Simon R, Diallo R, Poremba C, Dockhorn-Dworniczak B, van Diest PJ, Boecker W. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two diff erent lines of genetic evolution. J Pathol. 2001; 194:165170. Go to original source... Go to PubMed...
    28. Bednarek AK, Keck-Waggoner CL, Daniel RL, Lafl in KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 2001; 61:8068 73.
    29. Nunez MI, Ludes-Meyers J, Abba MC, Kil H, Abbey NW, Page RE, Sahin A, Klein-Szanto AJ, Aldaz CM. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status, Cancer Research and Treatment 2005; 89:99105. Go to original source...
    30. Pluciennik E, Kusinska R, Potemski P, Kubiak R, Kordek R, Bednarek AK WWOX-the FRA16D cancer gene: Expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol. 2006; 32(2), 1537. Go to original source... Go to PubMed...
    31. Wezel T, Lombaerts M, Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Research 2005; 7:R998R1004. Go to original source... Go to PubMed...
    32. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K. The Fragile Genes FHIT and WWOX Are Inactivated Coordinately in Invasive Breast Carcinoma. Cancer 2004; 100(8):160514. Go to original source... Go to PubMed...
    33. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, McCue P, Huebner K. Concordant loss of fragile gene expression early in breast cancer development. Pathology International 2005; 55: 471 478. Go to original source... Go to PubMed...
    34. Chang NS, Schultz L, Hsu LJ, Lewis J, Su M, Sze CI. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene 2005; 24(4), 714-23. Go to original source... Go to PubMed...
    35. Mahajan NP, Whang YE, Mohler JL, Earp HS. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res. 2005; 65(22):10514-23. Go to original source... Go to PubMed...
    36. Nunez MI, Rosen DG, Ludes-Meyers JH., Abba MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB, Aldaz CM. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer 2005; 5:64. Go to original source... Go to PubMed...
    37. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML, Williams NN, Mori M, Kanematsu T, Croce CM. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 2004; 10:245965. Go to original source... Go to PubMed...
    38. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, Druck T, Trapasso F, Han SY, Melino G, Huebner K, Croce CM. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci 2004; 101:44016. Go to original source...
    39. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809819. Go to original source... Go to PubMed...
    40. Jost CA, Marin MC, Kaelin WJ. P73 is a human p53-related protein that can induce apoptosis. Nature 1997; 389:191-194. Go to original source... Go to PubMed...
    41. Melino G, De Laurenzi V, Vousden K H. p73: Friend or foe in tumorigenesis. Nat. Rev. Cancer 2002; 2:605615. Go to original source... Go to PubMed...
    42. Inoue T, Stuart J, Leno R, Maki CG. Nuclear import and export signals in control of the p53-related protein p73. J. Biol. Chem. 2002; 277:1505315060. Go to original source... Go to PubMed...
    43. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D. p73-defi cient mice have neurological, pheromonal and infl ammatory defects but lack spontaneous tumours. Nature 2000; 404:99 103. Go to original source... Go to PubMed...
    44. Chang NS, Pratt N, Heath J, Schultz L, Sleve D, Carey GB, Zevotek N. Hyaluronidase induction of a WW domain containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem 2001; 276:336170. Go to original source... Go to PubMed...
    45. Chang NS, Doherty J, Ensign A. JNK1 physically interacts with WW domaincontaining oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem 2003; 278:9195202. Go to original source... Go to PubMed...
    46. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and Functional Interactions between the Wwox Tumor Suppressor Protein and the AP-2_ Transcription Factor. Cancer Res 2004; 64:82568261. Go to original source... Go to PubMed...
    47. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y, Sudol M, Croce CM. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 2005; 65:676472. Go to original source... Go to PubMed...
    48. Sze CI, Su M, Pugazhenthi S, Jambal P, Hsu LJ, Heath J, Schultz L, Chang NS. Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro. A potential role in Alzheimer's disease. J Biol Chem. 2004; 279(29):30498 506. Go to original source... Go to PubMed...
    49. Chen ST, Chuang JI, Wang JP, Tsai MS, Li H, Chang NS. Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system. Neuroscience 2004; 124:831839. Go to original source... Go to PubMed...
    50. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res 2000; 60:16839.
    51. Kuroki T, Tajima Y, Furui J, Kanematsu T. Common Fragile Genes and Digestive Tract Cancers. Surg Today 2006; 36:15. Go to original source...
    52. Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer 2004; 91:7539. Go to original source... Go to PubMed...
    53. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan R, Cimmino A, Zanesi N, Yendamuri S, Han S, Amadori D, Huebner K, Croce CM. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. PNAS 2005; 25:1561115616. Go to original source...
    54. Iliopoulos D, Guler G, Han S Y, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baff a R, Huebner K. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Oncogene 2005; 24:16251633. Go to original source...

    Return to the content